Journal article
Editorial An optimum prophylactic dose of prasugrel monotherapy may safely and effectively prevent the development of experimental thrombotic strokes
Authors
Ofosu FA
Journal
Thrombosis Research, Vol. 136, No. 6, pp. 1053–1054
Publisher
Elsevier
Publication Date
December 1, 2015
DOI
10.1016/j.thromres.2015.10.023
ISSN
0049-3848